Andersons Inc.
http://www.andersonsinc.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Andersons Inc.
Duloxetine Gains Wane In U.S. As New India, Other Generic Entrants Disrupt Pricing
After making handsome gains from selling generic versions of duloxetine Eli Lilly’s blockbuster anti-depression brand Cymbalta, companies are under pressure from the second wave of offerings.
Medical Device and In Vitro Diagnostics Deal Statistics Quarterly, Q4 2007
Highlights from the Q4 2007 review of medical device and in vitro diagnostics/research dealmaking: there was a boost in medical device acquisitions--with patient monitoring in particular, which accounted for about half the total of this period--capping off an impressive year in medtech M&A activity. Of note in the in vitro diagnostics/research space was glucose monitoring, which brought in 60% of the total GM segment's $160 million in financing for the entire year.
Deal Statistics Quarterly, Q2 2004
Statistical review compiled from our Strategic Transactions database including financings by type (IPO, private placement etc.); financings by sector (surgical equipment, implantable devices, etc.); alliances by therapeutic category (cardiovascular, orthopedic, etc.); alliances by industry segment (biomaterials, monitoring equipment, etc. ); for three separate industries: medical devices, in vitro diagnostics, and pharmaceuticals/biotechnology.
Recent Dealmaking (05/2003)
Summarizing the month in European dealmaking.
Company Information
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice